MedPath

Dex-Moxi PF

Approved
Approval ID

6bb78fd2-5d72-1b41-e053-2991aa0af497

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 8, 2018

Manufacturers
FDA

ImprimisRx NJ

DUNS: 931390178

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Dexamethasone - Moxifloxacin PF

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70261-512
Product Classification
G
Generic Name
Dexamethasone - Moxifloxacin PF
Product Specifications
Route of AdministrationINTRAOCULAR
Effective DateMay 8, 2018
FDA Product Classification

INGREDIENTS (2)

DEXAMETHASONE SODIUM PHOSPHATEActive
Quantity: 1 mg in 1 mL
Code: AI9376Y64P
Classification: ACTIR
MOXIFLOXACIN HYDROCHLORIDE MONOHYDRATEActive
Quantity: 5 mg in 1 mL
Code: B8956S8609
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Dex-Moxi PF - FDA Drug Approval Details